Can the EC Boost Europe's Competitiveness?
Executive Summary
The European Commission is trying to turn Europe into a more competitive player in the global pharmaceutical market, through speeding up and streamlining the pre-market drug approvals process, including implementation of a new US-style "fast-track" alternative. But without simultaneous reforms in pricing and reimbursement by member states, loosening of marketing restrictions isn't likely to have much impact.